Alpha Teknova, Inc. $TKNO
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Hollister, CA
- Fiscal year end
- December 31
- Shares outstanding
- 53,688,246 [10-Q 2026-08-06]
What the company doesAI summary of filing
Alpha Teknova is a revenue-generating manufacturer of chemical reagents and culture media used in life sciences research, drug development, and manufacturing. The company produces three primary product types—pre-poured media plates, liquid microbial culture media and supplements, and molecular biology reagents—sold under two categories: Lab Essentials (research-grade products representing 76.6% of 2025 revenue) and Clinical Solutions (GMP-grade products representing 18.9% of 2025 revenue). It serves over 3,000 customers including pharmaceutical and biotechnology companies, contract manufacturers, diagnostic companies, and academic institutions, with approximately 95% customer retention among accounts spending over $10,000 annually. The company manufactures custom and catalog formulations at its facilities in Hollister, California, and generated revenue in the year ended December 31, 2025, though it reported a net loss of $17.3 million for that period. [10-K 2026-03-02]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $23.26M | −$7.72M | −$3.83M | $6.00M | [10-Q 2026-08-06] |
| FY ended Dec 2025 | $40.52M | −$17.26M | −$8.65M | $5.91M | [10-K 2026-03-02] |
| FY ended Dec 2024 | $37.74M | −$26.75M | −$12.39M | $3.71M | [10-K 2026-03-02] |
- Quarterly cash burn
- −$1.92M
- Cash runway Estimate
- ~9.4 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-07 | 53,307,689 | [10-Q 2024-11-08] |
| 2025-03-05 | 53,436,806 | [10-K 2025-03-07] |
| 2025-05-07 | 53,440,810 | [10-Q 2025-05-09] |
| 2025-08-06 | 53,515,167 | [10-Q 2025-08-08] |
| 2025-11-05 | 53,529,174 | [10-Q 2025-11-07] |
| 2026-02-27 | 53,587,662 | [10-K 2026-03-02] |
| 2026-05-05 | 53,614,028 | [10-Q 2026-05-07] |
| 2026-08-05 | 53,688,246 | [10-Q 2026-08-06] |
- Shelf registration
- S-3 filed 2025-07-10; declared effective 2025-07-16 [S-3 2025-07-10]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-14 | Demski Martha J | other | 12,000 | — | [4 2026-07-16] |
| 2026-07-14 | Demski Martha J | other | 12,000 | — | [4 2026-07-16] |
| 2026-03-06 | Lowell Matthew | buy | 40,000 | $2.19 | [4 2026-03-09] |
| 2026-03-06 | Gunstream Stephen | buy | 26,000 | $2.15 | [4 2026-03-09] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-08-05 | 8-K | Results of operations |
| 2026-06-01 | 8-K | Director or officer change; Shareholder vote results |
| 2026-05-07 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Results of operations |
| 2026-04-21 | DEF 14A | Proxy statement |
| 2026-03-02 | 10-K | Annual report |
| 2026-02-26 | 8-K | Results of operations |
| 2025-11-07 | 10-Q | Quarterly report |
| 2025-11-06 | 8-K | Results of operations |
Alerts for $TKNO
Email me when Alpha Teknova, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.